The Emcure Research Centre (ERC) will drive research across multiple dosage forms, including OSD, injectables, novel drug delivery systems (NDDS), inhalers and topical and transdermal formulations
Infections with H. pylori affect over 43 percent of the world’s population with a wide range of gastrointestinal disorders
The technical program will run in four sessions and a panel discussion on “Challenges in translation of medical technologies”
Harnessing advanced data analysis for early detection, prevention and better outcomes
To set a new standard in oncology, offering highly targeted radiation therapy that improves treatment precision, and accelerates recovery for cancer patients
Coal India has committed to providing upto Rs. 3 crore to treat thalassaemia and aplastic anaemia patients for a period of 3 years
ForDoz Pharma Corporation, USA (ForDoz) received an approval for its ANDA from the USFDA
The discussion at the fourth session was centered on the fusion of academic rigor and industrial pragmatism as a key to pioneering solutions for sustainable and prosperous future
Around 7% of the Indian population suffers from IBS
With just few days of treatment, the patient started responding well and finally complete clinical resolution of infection was attained
Subscribe To Our Newsletter & Stay Updated
